NCT04699656View on ClinicalTrials.gov

Plazomicin Study in ESRD Patients Receiving IHD

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 5, 2021

Primary Completion Date

March 8, 2021

Study Completion Date

June 9, 2021

Conditions
End Stage Renal Disease
Interventions
DRUG

Plazomicin Injection

single dose of plazomicin

Trial Locations (1)

32809

Orlando Clinical Research Center, Orlando

Sponsors

Lead Sponsor

Cipla USA Inc.
All Listed Sponsors
lead

Cipla USA Inc.

INDUSTRY

NCT04699656 - Plazomicin Study in ESRD Patients Receiving IHD | Biotech Hunter | Biotech Hunter